Autosome

Autosome

Autosomes are chromosomes that do not determine an organism’s sex. In diploid cells, autosomes occur in homologous pairs whose members exhibit the same morphology, size, and gene arrangement, unlike allosomes, which may differ structurally. Autosomal DNA, often abbreviated as atDNA or auDNA, encompasses the genetic material carried on these non-sex chromosomes and forms the majority of the human genome.
Humans typically possess 22 pairs of autosomes alongside one pair of allosomes, resulting in a total of 46 chromosomes in each somatic cell. Autosomal pairs are numbered 1 to 22 according to their relative lengths, whereas the sex chromosomes are recognised by letters. Although autosomes are not classed as sex chromosomes, they still harbour genes essential for sexual development and many other biological functions.

Structure and Characteristics of Autosomes

Autosomes exist as homologous pairs in diploid organisms, each pair containing one chromosome inherited from the maternal parent and one from the paternal parent. They are fundamentally similar in:

  • Length and centromere position
  • Banding pattern when stained
  • Gene loci and arrangement

Their structural consistency allows for precise comparison between individuals and populations. The same does not apply to allosomes, as the X and Y chromosomes differ markedly in size, gene content, and morphology.
Autosomes encode the bulk of an individual’s genetic information, including the genes responsible for growth, metabolism, and physiological function. They also contain regulatory sequences and structural DNA crucial for chromosomal integrity.

Role in Human Sexual Development

Although the sex-determining region is located on the Y chromosome, autosomes contribute significantly to sexual differentiation. The SRY gene encodes Testis Determining Factor (TDF), which activates pathways responsible for male sex development. A key target of TDF is the SOX9 gene, situated on Chromosome 17. Mutations in SOX9 may lead to sex reversal conditions, where individuals with a typical XY chromosomal makeup develop phenotypically as females.
Unusual combinations of allosomes—such as XYY, Klinefelter syndrome (XXY), Triple X (XXX), XXXX, XXXXX, or XXYY—can lead to developmental abnormalities but do not alter the standard set of autosomes.

Identification and Mapping of Autosomes

Human autosomes were identified and systematically mapped using cytogenetic techniques. Cells are typically arrested in metaphase or prometaphase, when chromosomes are most condensed and visible. They are commonly stained using Giemsa dye, producing characteristic G-banding patterns.
These stained chromosomes are arranged into karyograms, ordered visual representations of an individual’s chromosome set. Karyograms allow geneticists to compare an individual’s chromosomes to reference standards to diagnose chromosomal abnormalities. For example:

  • Patau syndrome can be identified by the presence of three copies of Chromosome 13.
  • Structural disruptions such as deletions, duplications, or translocations larger than several million base pairs may also be detected.
  • Smaller aberrations typically require more sensitive molecular techniques.

Autosomal Genetic Disorders

Autosomal disorders may result from changes in chromosome number, structure, or gene function. They can be broadly categorised into Mendelian disorders and chromosomal abnormalities.
Mendelian autosomal disorders follow predictable patterns of inheritance:

  • Autosomal dominant disorders require only one copy of a deleterious allele for a phenotype to manifest. Affected individuals commonly have one affected parent.
  • Autosomal recessive disorders appear only when an individual inherits two copies of the harmful allele. Two phenotypically normal carriers may have affected offspring.

These disorders occur with equal frequency in males and females, as autosomes are inherited similarly regardless of sex.

Autosomal Aneuploidy

Aneuploidy involves an abnormal number of chromosomes and often has severe developmental consequences. Autosomal aneuploidies are generally less tolerated than anomalies involving sex chromosomes.
Key characteristics include:

  • Monosomy, or possession of only one copy of an autosome, is almost always lethal and usually results in early embryonic loss.
  • Trisomy, the presence of three copies of an autosome, is more compatible with life but still carries substantial developmental impacts.

Down syndrome is a notable example of autosomal trisomy, caused by an additional copy of Chromosome 21. Fetuses with trisomy on gene-rich autosomes such as Chromosome 1 do not survive to term, whereas trisomy of gene-poor chromosomes like Chromosome 21 may permit survival but still results in significant miscarriage rates.

Partial Aneuploidy and Translocations

Chromosomal translocations during meiosis can result in partial monosomies or trisomies:

  • Deletions lead to partial monosomy, in which segments of chromosomes are missing.
  • Duplications produce partial trisomy, encompassing extra chromosomal segments.

Larger deletions or duplications may be visible on a karyogram. Autosomal translocations are associated with a spectrum of conditions, including certain cancers and neurodevelopmental disorders such as schizophrenia.
Importantly, disorders arising from aneuploidy result from abnormal gene dosage rather than the absence of gene function. The imbalance in gene expression disrupts normal developmental pathways.

Applications and Clinical Significance

Autosomes hold central importance in medical genetics, evolutionary biology, and forensic science. They are used in:

  • Diagnostic testing, particularly for identifying congenital disorders and chromosomal syndromes.
  • Carrier screening, especially for autosomal recessive conditions.
  • Forensic analysis, as autosomal DNA provides high-resolution identification due to its biparental inheritance.
  • Population genetics, offering insights into ancestry, migration, and evolutionary relationships.
Originally written on August 2, 2018 and last modified on November 18, 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *